Published in Gene Therapy Weekly, May 1st, 2003
"While human prostate cancers and cell lines express Fas, most of these cell lines are resistant to Fas-mediated death. ... [W]e addressed the ability of IFN-gamma to influence Fas-mediated cell death in prostate cancer cells," said W.A. Selleck and colleagues.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.